137 related articles for article (PubMed ID: 30034881)
1. Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types.
Hadni H; Mazigh M; Charif E; Bouayad A; Elhallaoui M
Biochem Res Int; 2018; 2018():8639173. PubMed ID: 30034881
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and QSAR studies for modeling the antimalarial activity of hybrids 4-anilinoquinoline-triazines derivatives with the wild-type and mutant receptor
Hadni H; Elhallaoui M
Heliyon; 2019 Aug; 5(8):e02357. PubMed ID: 31485537
[No Abstract] [Full Text] [Related]
3. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
6. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4-aminoquinoline-pyrimidine molecular hybrids.
Maurya SS; Khan SI; Bahuguna A; Kumar D; Rawat DS
Eur J Med Chem; 2017 Mar; 129():175-185. PubMed ID: 28222317
[TBL] [Abstract][Full Text] [Related]
9. DFT-based reactivity and combined QSAR, molecular docking of 1,2,4,5-Tetrazine derivatives as inhibitors of Pim-1 kinase.
Hazhazi H; Melkemi N; Salah T; Bouachrine M
Heliyon; 2019 Sep; 5(9):e02451. PubMed ID: 31687555
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS.
Sahu S; Ghosh SK; Kalita J; Dutta M; Bhat HR
Exp Parasitol; 2016 Apr; 163():38-45. PubMed ID: 26821296
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of antimalarial activity of new derivatives of 2,4,6-s-triazine.
Pathak M; Ojha H; Tiwari AK; Sharma D; Saini M; Kakkar R
Chem Cent J; 2017 Dec; 11(1):132. PubMed ID: 29256159
[TBL] [Abstract][Full Text] [Related]
12. 2D-QSAR and docking study of a series of coumarin derivatives as inhibitors of CDK (anticancer activity) with an application of the molecular docking method.
Kasmi R; Hadaji E; Chedadi O; El Aissouq A; Bouachrine M; Ouammou A
Heliyon; 2020 Aug; 6(8):e04514. PubMed ID: 32817887
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives.
Bhat HR; Ghosh SK; Prakash A; Gogoi K; Singh UP
Lett Appl Microbiol; 2012 May; 54(5):483-6. PubMed ID: 22394198
[TBL] [Abstract][Full Text] [Related]
14. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
15. Free energy force field (FEFF) 3D-QSAR analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors.
Santos-Filho OA; Mishra RK; Hopfinger AJ
J Comput Aided Mol Des; 2001 Sep; 15(9):787-810. PubMed ID: 11776291
[TBL] [Abstract][Full Text] [Related]
16. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives.
Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM
Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759
[TBL] [Abstract][Full Text] [Related]
18. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
Ojha PK; Roy K
Med Chem; 2011 May; 7(3):173-99. PubMed ID: 21486210
[TBL] [Abstract][Full Text] [Related]
19. QSAR analysis of benzophenone derivatives as antimalarial agents.
Mahajan S; Kamath V; Nayak S; Vaidya S
Indian J Pharm Sci; 2012 Jan; 74(1):41-7. PubMed ID: 23204621
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Different 2D and 3D-QSAR Methods on Activity Prediction of Histamine H3 Receptor Antagonists.
Dastmalchi S; Hamzeh-Mivehroud M; Asadpour-Zeynali K
Iran J Pharm Res; 2012; 11(1):97-108. PubMed ID: 25317190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
